Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP045447priorityCriticalpatent/ECSP045447A/en
Publication of ECSP045447ApublicationCriticalpatent/ECSP045447A/en
239000002587phosphodiesterase IV inhibitorSubstances0.000abstract1
230000009885systemic effectEffects0.000abstract1
230000000699topical effectEffects0.000abstract1
Landscapes
Medicinal Preparation
(AREA)
Abstract
Se describe una preparación farmacéutica tópica para la administración de un inhibidor de PDE 4 ligeramente soluble. Se observó una biodisponibilidad sistémica sorprendentemente buena con esta forma de dosificación.A topical pharmaceutical preparation for the administration of a slightly soluble PDE 4 inhibitor is described. Surprisingly good systemic bioavailability was observed with this dosage form.
ECSP0454472004-11-242004-11-24
PHARMACEUTICAL PREPARATION THAT CAN BE APPLIED BY TOPIC
ECSP045447A
(en)
Formulation suitable for subcutaneous administration comprising at least 100 mg / ml of ctlaig, a sugar, and a pharmaceutically stable aqueous carrier; article of manufacture comprising at least one container containing the aforementioned formulation. (divisional application n ° 3597-06)